(1) 28 myomectomies were performed in office setting and 14 in ambulatory surgical center setting. (2) The mean percentage of pathology removed was %. (3) Both Uterine Fibroid Symptom-Quality of Life and Health-Related Quality of Life improved significantly 12 months after procedure. (4) A fluid deficit of nearly 4 Lt was reported in at least one patient.
2 patients with myoma protrusion < 60%, 11 patients > 60%; 9 small (≤3 cm) myomas, 4 large (>3 cm) myomas
MyoSure
36.6
1005
(1) No significant differences in overall patient satisfaction and improvement in hemoglobin level between intrauterine morcellation and resectoscopy at 3-month follow-up. (2) HTRs significantly reduced operative time.
(1) All patients had successful removal of pathology apart from two partial myomectomies (calcified fibroids) and one failed MyoSure for patulous cervix. (2) No complications occurred. (3) Intrauterine morcellation is feasible also in outpatient setting.
No significant differences for mean operative time, complete resection rate, adverse events, and postoperative adhesion between HTRs and bipolar loop resection.
(1) All procedures were uneventful. (2) Implementation of the HTRs for removal of type 0 and 1 myomas ≤ 3 cm, and removal of polyps appears safe and effective.
HTRs: Hysteroscopic Tissue Removal systems; NA: not available.